{"entity":{"type":"insider","cik":"0001491140","url":"/insider/0001491140","json_url":"/insider/0001491140.json","name":"O'Toole David D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":63,"n_filings":48,"first":"2012-02-06","last":"2026-08-24","span_basis":"filed_date"},"name_variants":[{"name":"O'Toole David D","source":"filing","n_filings":48,"first_seen":"2012-02-06","last_seen":"2026-08-24"}],"transactions":[{"id":9300893,"accession":"0001193125-26-363747","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-363747","line_url":"/filing/0001193125-26-363747#line-1","is_derivative":false,"issuer_cik":"0001762303","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001762303","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.97,"price_display":"3.97","price_state":"stated","total_value":7940.0,"total_display":"7,940.00","total_whole":"7,940","shares_owned_after":152927.0,"shares_owned_after_display":"152,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-08-24","scope":"insider"},{"id":6062742,"accession":"0001193125-26-232686","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-232686","line_url":"/filing/0001193125-26-232686#line-1","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.26,"price_display":"4.26","price_state":"stated","total_value":8520.0,"total_display":"8,520.00","total_whole":"8,520","shares_owned_after":145927.0,"shares_owned_after_display":"145,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-20","scope":"insider"},{"id":5837350,"accession":"0001193125-26-230874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-230874","line_url":"/filing/0001193125-26-230874#line-1","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.24,"price_display":"4.24","price_state":"stated","total_value":8480.0,"total_display":"8,480.00","total_whole":"8,480","shares_owned_after":143927.0,"shares_owned_after_display":"143,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-19","filed_date":"2026-05-19","scope":"insider"},{"id":5894039,"accession":"0001193125-26-102263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-102263","line_url":"/filing/0001193125-26-102263#line-1","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800.0,"shares_display":"1,800","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":8604.0,"total_display":"8,604.00","total_whole":"8,604","shares_owned_after":141927.0,"shares_owned_after_display":"141,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-11","scope":"insider"},{"id":5929659,"accession":"0001193125-26-064111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-064111","line_url":"/filing/0001193125-26-064111#line-1","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":12450.0,"total_display":"12,450.00","total_whole":"12,450","shares_owned_after":140127.0,"shares_owned_after_display":"140,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-19","filed_date":"2026-02-23","scope":"insider"},{"id":4027958,"accession":"0000950170-25-111467","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-111467","line_url":"/filing/0000950170-25-111467#line-1","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.52,"price_display":"4.52","price_state":"stated","total_value":9040.0,"total_display":"9,040.00","total_whole":"9,040","shares_owned_after":31657.0,"shares_owned_after_display":"31,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-26","scope":"insider"},{"id":4619945,"accession":"0000950170-25-107387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-107387","line_url":"/filing/0000950170-25-107387#line-1","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.81,"price_display":"4.81","price_state":"stated","total_value":9620.0,"total_display":"9,620.00","total_whole":"9,620","shares_owned_after":29657.0,"shares_owned_after_display":"29,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-12","scope":"insider"},{"id":5030755,"accession":"0000950170-25-024204","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-024204","line_url":"/filing/0000950170-25-024204#line-1","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.9,"price_display":"9.90","price_state":"stated","total_value":9900.0,"total_display":"9,900.00","total_whole":"9,900","shares_owned_after":25734.0,"shares_owned_after_display":"25,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-20","scope":"insider"},{"id":4416220,"accession":"0000950170-25-023233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-023233","line_url":"/filing/0000950170-25-023233#line-1","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":10.25,"price_display":"10.25","price_state":"stated","total_value":10250.0,"total_display":"10,250.00","total_whole":"10,250","shares_owned_after":24734.0,"shares_owned_after_display":"24,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-19","scope":"insider"},{"id":2243308,"accession":"0000950170-24-133748","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-133748","line_url":"/filing/0000950170-24-133748","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":975.0,"shares_display":"975","price_per_share":12.463333333333333,"price_display":"12.46","price_state":"stated","total_value":12151.75,"total_display":"12,151.75","total_whole":"12,152","shares_owned_after":23734.0,"shares_owned_after_display":"23,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-05","filed_date":"2024-12-05","scope":"insider","n_lines":2},{"id":2460654,"accession":"0000950170-24-068006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-068006","line_url":"/filing/0000950170-24-068006","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.9,"price_display":"8.90","price_state":"stated","total_value":8900.0,"total_display":"8,900.00","total_whole":"8,900","shares_owned_after":19234.0,"shares_owned_after_display":"19,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-06-03","scope":"insider","n_lines":2},{"id":2983191,"accession":"0000950170-24-022050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-022050","line_url":"/filing/0000950170-24-022050","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":17.39,"price_display":"17.39","price_state":"stated","total_value":21737.5,"total_display":"21,737.50","total_whole":"21,738","shares_owned_after":18484.0,"shares_owned_after_display":"18,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-02-28","scope":"insider","n_lines":2},{"id":8192805,"accession":"0000950170-23-069750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-069750","line_url":"/filing/0000950170-23-069750#line-1","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":950.0,"shares_display":"950","price_per_share":12.45,"price_display":"12.45","price_state":"stated","total_value":11827.5,"total_display":"11,827.50","total_whole":"11,828","shares_owned_after":17484.0,"shares_owned_after_display":"17,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-12","scope":"insider"},{"id":8108734,"accession":"0000950170-23-067875","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-067875","line_url":"/filing/0000950170-23-067875#line-2","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":10.68,"price_display":"10.68","price_state":"stated","total_value":5340.0,"total_display":"5,340.00","total_whole":"5,340","shares_owned_after":16534.0,"shares_owned_after_display":"16,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-04","scope":"insider"},{"id":8724370,"accession":"0000950170-23-065502","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-065502","line_url":"/filing/0000950170-23-065502","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":10.28,"price_display":"10.28","price_state":"stated","total_value":20560.0,"total_display":"20,560.00","total_whole":"20,560","shares_owned_after":14000.0,"shares_owned_after_display":"14,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-21","scope":"insider","n_lines":2},{"id":8465447,"accession":"0000950170-23-064444","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-064444","line_url":"/filing/0000950170-23-064444#line-2","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":12.15,"price_display":"12.15","price_state":"stated","total_value":12150.0,"total_display":"12,150.00","total_whole":"12,150","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-16","scope":"insider"},{"id":8530633,"accession":"0000950170-23-064208","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-064208","line_url":"/filing/0000950170-23-064208#line-2","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":13.25,"price_display":"13.25","price_state":"stated","total_value":13250.0,"total_display":"13,250.00","total_whole":"13,250","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-15","scope":"insider"},{"id":8465443,"accession":"0000950170-23-064444","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-064444","line_url":"/filing/0000950170-23-064444#line-1","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":12.45,"price_display":"12.45","price_state":"stated","total_value":12450.0,"total_display":"12,450.00","total_whole":"12,450","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-16","scope":"insider"},{"id":8530628,"accession":"0000950170-23-064208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-064208","line_url":"/filing/0000950170-23-064208#line-1","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":12.88,"price_display":"12.88","price_state":"stated","total_value":12880.0,"total_display":"12,880.00","total_whole":"12,880","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-15","scope":"insider"},{"id":7801168,"accession":"0000950170-23-043056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-043056","line_url":"/filing/0000950170-23-043056","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":17.055,"price_display":"17.06","price_state":"stated","total_value":34110.0,"total_display":"34,110.00","total_whole":"34,110","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-16","scope":"insider","n_lines":2},{"id":8724241,"accession":"0000950170-23-042840","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-23-042840","line_url":"/filing/0000950170-23-042840","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":17.928,"price_display":"17.93","price_state":"stated","total_value":89640.0,"total_display":"89,640.00","total_whole":"89,640","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-15","scope":"insider","n_lines":5},{"id":8254326,"accession":"0001209191-23-038909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-038909","line_url":"/filing/0001209191-23-038909#line-1","is_derivative":false,"issuer_cik":"0001491140","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001491140","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":16.15,"price_display":"16.15","price_state":"stated","total_value":16150.0,"total_display":"16,150.00","total_whole":"16,150","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-21","scope":"insider"},{"id":8664576,"accession":"0001385508-23-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-23-000030","line_url":"/filing/0001385508-23-000030#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":541.0,"shares_display":"541","price_per_share":20.26,"price_display":"20.26","price_state":"stated","total_value":10960.66,"total_display":"10,960.66","total_whole":"10,961","shares_owned_after":34248.0,"shares_owned_after_display":"34,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-31","scope":"insider"},{"id":8560459,"accession":"0001385508-23-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-23-000024","line_url":"/filing/0001385508-23-000024#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":415.0,"shares_display":"415","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":8383.0,"total_display":"8,383.00","total_whole":"8,383","shares_owned_after":34789.0,"shares_owned_after_display":"34,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-09","scope":"insider"},{"id":8261437,"accession":"0001385508-23-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-23-000011","line_url":"/filing/0001385508-23-000011#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":32320.0,"total_display":"32,320.00","total_whole":"32,320","shares_owned_after":35204.0,"shares_owned_after_display":"35,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-05","scope":"insider"},{"id":6159474,"accession":"0001385508-22-000112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000112","line_url":"/filing/0001385508-22-000112#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":779.0,"shares_display":"779","price_per_share":11.1,"price_display":"11.10","price_state":"stated","total_value":8646.9,"total_display":"8,646.90","total_whole":"8,647","shares_owned_after":36804.0,"shares_owned_after_display":"36,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-14","filed_date":"2022-07-15","scope":"insider"},{"id":6114452,"accession":"0001385508-22-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000022","line_url":"/filing/0001385508-22-000022#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":432.0,"shares_display":"432","price_per_share":30.6,"price_display":"30.60","price_state":"stated","total_value":13219.2,"total_display":"13,219.20","total_whole":"13,219","shares_owned_after":35583.0,"shares_owned_after_display":"35,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-12","scope":"insider"},{"id":4805040,"accession":"0001385508-21-000132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-21-000132","line_url":"/filing/0001385508-21-000132","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":19.1216,"price_display":"19.12","price_state":"stated","total_value":3824.32,"total_display":"3,824.32","total_whole":"3,824","shares_owned_after":23994.0,"shares_owned_after_display":"23,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-15","scope":"insider","n_lines":2},{"id":4500642,"accession":"0001385508-21-000111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-21-000111","line_url":"/filing/0001385508-21-000111#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":15.38,"price_display":"15.38","price_state":"stated","total_value":9228.0,"total_display":"9,228.00","total_whole":"9,228","shares_owned_after":23815.0,"shares_owned_after_display":"23,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-16","scope":"insider"},{"id":2845285,"accession":"0001385508-20-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-20-000067","line_url":"/filing/0001385508-20-000067#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":8740.0,"total_display":"8,740.00","total_whole":"8,740","shares_owned_after":15365.0,"shares_owned_after_display":"15,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-11","scope":"insider"},{"id":2092924,"accession":"0001385508-20-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-20-000061","line_url":"/filing/0001385508-20-000061#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":11000.0,"total_display":"11,000.00","total_whole":"11,000","shares_owned_after":14365.0,"shares_owned_after_display":"14,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-26","scope":"insider"},{"id":8177219,"accession":"0001385508-19-000121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-19-000121","line_url":"/filing/0001385508-19-000121#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":13.22,"price_display":"13.22","price_state":"stated","total_value":1322.0,"total_display":"1,322.00","total_whole":"1,322","shares_owned_after":9215.0,"shares_owned_after_display":"9,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-26","scope":"insider"},{"id":8129880,"accession":"0001385508-19-000117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000117","line_url":"/filing/0001385508-19-000117","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":14.918181818181818,"price_display":"14.92","price_state":"stated","total_value":16410.0,"total_display":"16,410.00","total_whole":"16,410","shares_owned_after":9015.0,"shares_owned_after_display":"9,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-15","scope":"insider","n_lines":2},{"id":8303770,"accession":"0001385508-19-000088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-19-000088","line_url":"/filing/0001385508-19-000088#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":15.2,"price_display":"15.20","price_state":"stated","total_value":15200.0,"total_display":"15,200.00","total_whole":"15,200","shares_owned_after":8015.0,"shares_owned_after_display":"8,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-15","scope":"insider"},{"id":8498673,"accession":"0001385508-19-000086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-19-000086","line_url":"/filing/0001385508-19-000086#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":15.46,"price_display":"15.46","price_state":"stated","total_value":15460.0,"total_display":"15,460.00","total_whole":"15,460","shares_owned_after":7015.0,"shares_owned_after_display":"7,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-13","scope":"insider"},{"id":5972319,"accession":"0001385508-18-000071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-18-000071","line_url":"/filing/0001385508-18-000071","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1015.0,"shares_display":"1,015","price_per_share":15.404926108374385,"price_display":"15.40","price_state":"stated","total_value":15636.0,"total_display":"15,636.00","total_whole":"15,636","shares_owned_after":6015.0,"shares_owned_after_display":"6,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-14","filed_date":"2018-08-14","scope":"insider","n_lines":2},{"id":6400798,"accession":"0001385508-18-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-18-000045","line_url":"/filing/0001385508-18-000045#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":16.95,"price_display":"16.95","price_state":"stated","total_value":33900.0,"total_display":"33,900.00","total_whole":"33,900","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-16","scope":"insider"},{"id":6278335,"accession":"0001385508-18-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-18-000041","line_url":"/filing/0001385508-18-000041#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001491140","owner_name":"O'Toole David D","owner_display_name":"O'Toole David D","owner_url":"/insider/0001491140","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":18.85,"price_display":"18.85","price_state":"stated","total_value":56550.0,"total_display":"56,550.00","total_whole":"56,550","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-11","filed_date":"2018-05-14","scope":"insider"}],"collapsed":true,"next_cursor":"2018-05-11|6278335","ledger_fault":false,"count":{"value":63,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":58,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":63},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001762303","name":"AVITA Medical, Inc.","url":"/issuer/0001762303","role":"Officer (CFO)","n_filings":20,"first_seen":"2023-06-21","last_seen":"2026-08-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001385508","name":"OPIANT PHARMACEUTICALS, INC.","url":"/issuer/0001385508","role":"Officer (Chief Financial Officer)","n_filings":16,"first_seen":"2018-05-14","last_seen":"2023-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001484565","name":"Capnia, Inc.","url":"/issuer/0001484565","role":"Officer","n_filings":7,"first_seen":"2015-03-16","last_seen":"2016-08-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001200375","name":"CODEXIS INC","url":"/issuer/0001200375","role":"Officer (SVP & Chief Financial Officer)","n_filings":3,"first_seen":"2012-09-14","last_seen":"2013-03-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001226616","name":"MEDICINOVA INC","url":"/issuer/0001226616","role":"Director","n_filings":1,"first_seen":"2012-05-30","last_seen":"2012-05-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001124608","name":"RESPONSE GENETICS INC","url":"/issuer/0001124608","role":"Officer (VP and Chief Financial Officer)","n_filings":1,"first_seen":"2012-02-06","last_seen":"2012-02-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001491140","retrieved_at":"2026-08-27T04:59:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}